Planning a pregnancy after Wegovy: what you need to know first

You've decided you want a baby, here is where semaglutide stands

You've been using Wegovy, weight is shifting in the right direction, and now you're thinking about starting a family. The first thing to know is that the clinical advice is clear and consistent: semaglutide should be stopped before you try to conceive. Reproductive toxicity studies in animals showed adverse effects at high doses, and there is simply not enough human data on outcomes during pregnancy to consider it safe to continue. The NHS medicines information for semaglutide states plainly that it is not recommended in pregnancy.

Beyond stopping, there is a wash-out period to consider. Semaglutide has a relatively long half-life, it stays active in the body for some time after the final dose. MHRA guidance advises using effective contraception while on GLP-1 medicines and for a period after stopping before attempting conception. Talk to your GP or prescriber about exactly how long that window should be for you; the detail is in the Patient Information Leaflet and your prescriber is the right person to interpret it for your circumstances. Timing this carefully is more important than it might first appear, and it is also worth thinking ahead about practical matters like taking Wegovy on holiday if you are still in the wash-out phase and travelling before you begin trying to conceive.

One thing people rarely plan for: weight can creep back once a GLP-1 medicine stops. That is not a reason to delay pregnancy, but it is worth having an honest conversation with your doctor about how to support your weight through diet and activity during the interval. If you are thinking through your options more broadly, the weight management approaches available in the UK give a useful starting point.

What is uncertain, and why that matters for conception timing

The honest answer is that data specific to conception outcomes after stopping Wegovy is limited. Most of the reproductive evidence comes from animal studies and from individual case reports rather than large controlled trials in humans. That is not unusual for a relatively new medicine, but it does mean the clinical community leans on caution rather than precision when advising on timelines.

What is reasonably well established is that semaglutide's weight-loss effect can itself improve fertility in women with obesity-related conditions such as polycystic ovary syndrome, where weight reduction sometimes restores more regular cycles. So stopping the medicine does not necessarily put you back at square one reproductively. For a fuller look at how semaglutide and conception interact, the question of whether Wegovy can affect pregnancy is covered in more detail on a dedicated page.

What remains uncertain is whether there are any residual effects on early foetal development if conception occurs shortly after the last dose. This is precisely why the wash-out advice exists. If you discover you are pregnant while still on semaglutide (something that happens, particularly if a change in GI absorption affected the reliability of oral contraception) stop treatment and contact your midwife or GP promptly. Report it to the MHRA's Yellow Card scheme too; that real-world data genuinely helps build the evidence base.

Starting Wegovy again after pregnancy and breastfeeding

Once your baby is here, the question often shifts to: when can I restart? The answer has two parts. First, semaglutide is not recommended while breastfeeding, it is not known whether it passes into breast milk in meaningful quantities, and until that is established the precautionary position is not to use it. So the practical timeline is: stop before trying to conceive, do not restart during pregnancy, do not restart while breastfeeding.

After breastfeeding ends, restarting is possible, but it is a fresh clinical assessment rather than a simple continuation. Your weight, any new health conditions from pregnancy, your BMI and your overall health picture will all be considered again. Many women find their weight after pregnancy sits differently from before, which can affect the clinical case for treatment. A prescriber will look at your eligibility against the licensed criteria for Wegovy, which cover the full picture of who the medicine is indicated for in the UK.

The other practical question is about cost. If you were paying privately before, it is worth understanding what your monthly outlay will be, the Wegovy price context in the UK has changed meaningfully since 2025 and is worth revisiting. If you're thinking about starting the conversation again (perhaps while the baby is still small and you're already juggling everything) our prescribers review consultations the same day, so there's no need to wait weeks for an appointment before getting an answer.

Having this conversation with the right people

A page like this can set out what is known. What it cannot do is tell you the right timeline for your specific body, your fertility history, or your weight-management goals after birth. That conversation belongs with your GP, a fertility specialist if you're already working with one, and the prescriber overseeing your semaglutide treatment.

If you are thinking about what comes next and want a clinical view before making any changes, our clinical team can speak to the weight-management side of the picture. For any queries that straddle fertility and weight medicine, your GP remains the central figure. You can also read more about the specific considerations around Wegovy and pregnancy or explore the broader evidence on semaglutide use in the context of pregnancy. If you're ready to think about restarting treatment once the time is right, a free consultation with our prescribers is the sensible first step.